X4 Pharmaceuticals Inc. Revenue 2018–2025
X4 Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- X4 Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 2.7 M, a 90.60% decrease year-over-year.
- X4 Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 35.3 M, a 3039.18% increase year-over-year.
- X4 Pharmaceuticals Inc. annual revenue for 2025 was 35.1 M, a 1273.21% increase from 2024.
- X4 Pharmaceuticals Inc. annual revenue for 2024 was 2.6 M.
- X4 Pharmaceuticals Inc. annual revenue for 2023 was 0.
- X4 Pharmaceuticals Inc. annual revenue for 2022 was 0.
X4 Pharmaceuticals Inc. (XFOR) — Frequently Asked Questions
X4 Pharmaceuticals Inc. (XFOR) is a publicly traded US company. It has a market capitalization of $158M. In fiscal 2025 it reported revenue of $35M and net income of -$79M. Explore XFOR's stock price, financial statements, earnings history, margins and key ratios below.
What is X4 Pharmaceuticals Inc.'s market cap?
X4 Pharmaceuticals Inc. (XFOR) has a market capitalization of $158M.
What is the XFOR stock price?
XFOR trades at $3.73 (-3.12% on the day).
How much revenue does X4 Pharmaceuticals Inc. make?
X4 Pharmaceuticals Inc. reported revenue of $35M in fiscal 2025.
Is XFOR profitable?
In fiscal 2025, X4 Pharmaceuticals Inc. reported net income of -$79M.